Clinical Study
A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years
Table 1
Patients’ characteristics and outcomes data.
| | | Before treatment | After treatment | value |
| | Fasting glucose (mg/dL SD) | 82.06 4.7 | 79.46 4.2 | 0.011 | | HOMA IR | 3.4 2.5 | 2.6 2.5 | 0.001 | | Homocysteine (µmol/L) | 9.10 2.6 | 8.54 2.39 | 0.008 | | Cholesterol (mg SD) | 174.7 41.0 | 160.3 29.5 | 0.005 | | LDL (mg SD) | 94 26.5 | 86.3 18.3 | 0.017 | | HDL (mg SD) | 47.7 6.5 | 48.6 6.9 | NS | | Triglyceride (mg SD) | 108.2 55.3 | 110.7 55.3 | NS | | Systolic blood pressure (mmHg) | 130 1.9 | 126 1.9 | 0.002 | | Diastolic blood pressure (mmHg) | 89 1.1 | 83 3.1 | 0.001 | | BMI (kg/m2 SD) | 26.9 3.4 | 26.8 3.4 | NS |
|
|
Statistically significant differences was observed.
HOMA IR: insulin resistance; LDL: low-density lipoprotein; HDL: high-density lipoprotein; BMI: body mass index; SD: standard deviation.
|
